Back to search

Spain· ES:81120

FOSFATO NM 3,56 G POLVO PARA SOLUCION ORAL

A medicinal product containing dihidrógenofosfato sodio, registered in Spain by Nutricion Medica S.L..

Checked against AEMPS CIMA (Spain) on

Informational only — not a medical device.

SOURCE REGISTER · ESAEMPS CIMA (Spain)normalisedFOSFATO NM 3,56 G POLVO PARA SOLUCION…ATC—REGISTER NO.ES:81120PACKS LISTED2CHECKEDJune 3, 2026

The record

At a glance

AEMPS CIMA (Spain)
Active substance
dihidrógenofosfato sodio
Manufacturer
Nutricion Medica S.L.
Country
Spain (ES)
ATC code
—
Reimbursed
Not published by this register
Source register
AEMPS CIMA (Spain)
Last checked
June 3, 2026

Packs & prices · 2

2 priced
  • cima_codigo
    712074
    20
    EUR 13.27
  • cima_codigo
    712076
    100
    EUR 39.34

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Dihidrógenofosfato sodio in 2 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All dihidrógenofosfato sodio products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AEMPS CIMA (Spain). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/15aa8ac2-a9d7-4a12-99e0-7614cb040cc4
GET /v1/drugs/15aa8ac2-a9d7-4a12-99e0-7614cb040cc4?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cpresc": "Medicamento Sujeto A Prescripción Médica",
  "estado": "{\"aut\":1470060879000}",
  "nregistro": "81120",
  "substance": "dihidrógenofosfato sodio"
}

See everything about dihidrógenofosfato sodio.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.